Please login to the form below

Not currently logged in
Email:
Password:

Nordics investigate vaccine narcolepsy link

Sweden and Finland have opened inquiries into whether the GSK swine flu vaccine Pandemrix is responsible for cases of narcolepsy in children

Läkemedelsverket, Sweden's Medical Products Agency (MPA), and Finland's National Institute for Health and Welfare (THL) have begun investigating if the GlaxoSmithKline (GSK) vaccine Pandemrix is responsible for cases of narcolepsy among children treated with the H1N1 "swine flu" drug. The investigations have been launched in response to physician reports.

The MPA has received six reports from healthcare professionals regarding narcolepsy as a suspected adverse drug reaction following Pandemrix flu vaccination," the Agency said in a statement.

These reports concern children aged 12-16 years who developed symptoms of narcolepsy within two months of inoculation with Pandemrix.

In Finland, the number of narcolepsy cases reported this year was 12-14, which is much higher than the average of three cases annually. This increase has prompted officials there to consider a link between the condition and either the vaccine or the flu itself. 

The Finnish cases were detected among children aged 5-15 years. Symptoms began between December and February, during the winter 2009/10 flu season, and the cases were diagnosed in early spring and summer.

Kerhi Kilpi, the director of THL's vaccine department, has said that she does not believe a link exists but that any doubts must be examined.

Preliminary results from the investigations are expected by the end of the year.

19th August 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics